These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 6335381

  • 1. Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.
    Dudley MN, Levitz RE, Quintiliani R, Hickingbotham JM, Nightingale CH.
    Antimicrob Agents Chemother; 1984 Dec; 26(6):811-4. PubMed ID: 6335381
    [Abstract] [Full Text] [Related]

  • 2. Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole.
    Grose WE, Bodey GP, Loo TL.
    Antimicrob Agents Chemother; 1979 Mar; 15(3):447-51. PubMed ID: 464572
    [Abstract] [Full Text] [Related]

  • 3. Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogens.
    Kamme C, Melander A, Nilsson NI.
    Scand J Infect Dis; 1983 Mar; 15(1):107-13. PubMed ID: 6342125
    [Abstract] [Full Text] [Related]

  • 4. Concentrations of trimethoprim and sulfamethoxazole in cerebrospinal fluid and serum in mares with and without a dimethyl sulfoxide pretreatment.
    Green SL, Mayhew IG, Brown MP, Gronwall RR, Montieth G.
    Can J Vet Res; 1990 Apr; 54(2):215-22. PubMed ID: 2357657
    [Abstract] [Full Text] [Related]

  • 5. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE, Blevins RB, Salem NG, Matzke GR.
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [Abstract] [Full Text] [Related]

  • 6. Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole.
    Wang EE, Prober CG.
    J Antimicrob Chemother; 1983 Apr; 11(4):385-9. PubMed ID: 6602124
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
    Nissenson AR, Wilson C, Holazo A.
    Am J Nephrol; 1987 Apr; 7(4):270-4. PubMed ID: 3500644
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and bioavailability of trimethoprim-sulfamethoxazole in alpacas.
    Chakwenya J, Lakritz J, Tyler J, Fales WH, James-Kracke M, Smith K, Holle J.
    J Vet Pharmacol Ther; 2002 Oct; 25(5):321-7. PubMed ID: 12423221
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
    Brown MP, Gronwall R, Castro L.
    Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after intravenous administration to healthy and pneumonic pigs.
    Mengelers MJ, Van Gogh ER, Kuiper HA, Pijpers A, Verheijden JH, Van Miert AS.
    J Vet Pharmacol Ther; 1995 Aug; 18(4):243-53. PubMed ID: 8583537
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR, Colby SD.
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [Abstract] [Full Text] [Related]

  • 12. Quantification of Serum Sulfamethoxazole and Trimethoprim by Ultra-fast Solid-Phase Extraction-Tandem Mass Spectrometry.
    Fatica E, Faber J, Gaffron C, Bjergum M, Langman L, Jannetto P.
    Ther Drug Monit; 2020 Oct; 42(5):724-732. PubMed ID: 32618880
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic failure of trimethoprim/sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia.
    al-Tawfiq JA, Sorensen SJ, Cushing HE.
    Ann Pharmacother; 1999 Apr; 33(4):413-5. PubMed ID: 10332530
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
    Siber GR, Gorham CC, Ericson JF, Smith AL.
    Rev Infect Dis; 1982 Apr; 4(2):566-78. PubMed ID: 6981173
    [Abstract] [Full Text] [Related]

  • 15. Intravenous pharmacokinetics and in vitro bactericidal activity of trimethoprim-sulfamethoxazole.
    Spicehandler J, Pollock AA, Simberkoff MS, Rahal JJ.
    Rev Infect Dis; 1982 Apr; 4(2):562-5. PubMed ID: 6981172
    [Abstract] [Full Text] [Related]

  • 16. Kinetic effects of trimethoprim-sulfamethoxazole in children with biliary atresia: a new dosing regimen.
    Lares-Asseff I, Villegas F, Pérez G, Toledo A, Camacho A, López DC.
    Arch Med Res; 1996 Apr; 27(2):183-90. PubMed ID: 8696062
    [Abstract] [Full Text] [Related]

  • 17. Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.
    Autmizguine J, Melloni C, Hornik CP, Dallefeld S, Harper B, Yogev R, Sullivan JE, Atz AM, Al-Uzri A, Mendley S, Poindexter B, Mitchell J, Lewandowski A, Delmore P, Cohen-Wolkowiez M, Gonzalez D, the Pediatric Trials Network Steering Committee.
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084742
    [Abstract] [Full Text] [Related]

  • 18. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
    Griffin PM, Tauxe RV, Redd SC, Puhr ND, Hargrett-Bean N, Blake PA.
    Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
    [Abstract] [Full Text] [Related]

  • 19. Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.
    Stein GE, Gurwith D, Gurwith M.
    Antimicrob Agents Chemother; 1988 Jun; 32(6):802-6. PubMed ID: 3046481
    [Abstract] [Full Text] [Related]

  • 20. High-dose co-trimoxazole and its penetration through uninflamed meninges.
    Goodwin CS, Bucens MC, Davis RE, Norcott TC.
    Med J Aust; 1981 Jul 11; 2(1):24-7. PubMed ID: 6974302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.